CAS 1686149-74-5

BMS-589154

CAS : 1686149-74-5

Formule : C₂₆H₂₇N₅O₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 473.5237

Ref: IN-DA00ASL3

Apixaban Impurity 4 (BMS-728626-01)

CAS : 1686149-74-5

Formule : C₂₆H₂₇N₅O₄

Couleur et forme : White To Off-White Solid

Masse moléculaire : 473.53

Ref: 4Z-A-10205

5''''-Methyl-apixaban

Produit contrôlé

CAS : 1686149-74-5

Impurity Apixaban
Applications Analytical standard impurity of drug.

Formule : C₂₆H₂₇N₅O₄

Couleur et forme : Neat

Masse moléculaire : 473.524

Ref: TR-M331278

1-(4-Methoxyphenyl)-6-(4-(5-methyl-2-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

CAS : 1686149-74-5

Degré de pureté : 98%

Masse moléculaire : 473.5329895019531

Ref: 10-F789888

Apixaban Impurity 4

CAS : 1686149-74-5

Formule : C₂₆H₂₇N₅O₄

Masse moléculaire : 473.53

Ref: ST-EA-CP-A3060

5''''-Methyl-apixaban

CAS : 1686149-74-5

5''''-Methyl-apixaban is a drug product that is synthesized in the laboratory. It has been shown to be metabolized by cytochrome P450 enzymes, which are found in the liver, and eliminated by glucuronidation. This compound has been shown to have antiplatelet activity and is used for the prevention of stroke in patients with atrial fibrillation who cannot tolerate warfarin or those who need a higher dose of warfarin than can be achieved with standard doses. 5''''-Methyl-apixaban also inhibits platelet aggregation, leading to decreased blood clot formation. 5''''-Methyl-apixaban has been shown to have a number of metabolites including apixaban, which is formed through oxidation; apixanone, which is formed through hydrolysis; and apixanol, which is formed through conjugation with glucuronic acid. Apixanone has been shown to have more potent antiplatelet activity

Formule : C₂₆H₂₇N₅O₄

Degré de pureté : Min. 95%

Masse moléculaire : 473.5 g/mol

Ref: 3D-LSC14974